Denibulin
Denibulin Uses, Dosage, Side Effects, Food Interaction and all others data.
Denibulin is a novel small molecule Vascular Disrupting Agent under development by MediciNova for treatment of solid tumor cancers.
Trade Name | Denibulin |
Generic | Denibulin |
Denibulin Other Names | Denibulin |
Type | |
Formula | C18H19N5O3S |
Weight | Average: 385.44 Monoisotopic: 385.120860666 |
Groups | Investigational |
Therapeutic Class | |
Manufacturer | |
Available Country | |
Last Updated: | September 19, 2023 at 7:00 am |
Uses
Investigated for use/treatment in solid tumors.
How Denibulin works
Denibulin selectively disrupts newly-formed tumor blood vessels, shutting down tumor blood flow and causing central necrosis of solid tumors. Consistent with its proposed mechanism of action, denibulin has been shown to reduce tumor blood flow resulting in tumor cell necrosis in rats bearing a human lung tumor xenograft. The present Phase I study now extends these findings (reductions in tumor blood flow) to cancer patients.
Innovators Monograph
You find simplified version here Denibulin